Flagship explainer
How GOLDENWELL BIOTECH, INC. makes its money
Start with a dollar of revenue and follow what the filing says remains.
Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.
| Filed line | Value | % of revenue | Source |
|---|---|---|---|
| $55 | 100% |
| |
| Cost of revenue | $43 | 78% |
|
| $12 | 22% |
| |
| −$113326 | −206047% |
| |
| Income before tax | −$296471 | −539038% |
|
| Income tax | $0 | 0% |
|
| −$296471 | −539038% |
|
Source:
- SEC filing · FY 2025Filing detailsAccession 0001477932-26-004130